Log in to save to my catalogue

Revisiting the role of pregnancy zone protein (PZP) as a cancer biomarker in the immunotherapy era

Revisiting the role of pregnancy zone protein (PZP) as a cancer biomarker in the immunotherapy era

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_57b97b9a66b24f6bb99f6a1c1e1d5bf2

Revisiting the role of pregnancy zone protein (PZP) as a cancer biomarker in the immunotherapy era

About this item

Full title

Revisiting the role of pregnancy zone protein (PZP) as a cancer biomarker in the immunotherapy era

Publisher

England: BioMed Central Ltd

Journal title

Journal of translational medicine, 2024-05, Vol.22 (1), p.500-5, Article 500

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Alternative Titles

Full title

Revisiting the role of pregnancy zone protein (PZP) as a cancer biomarker in the immunotherapy era

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_57b97b9a66b24f6bb99f6a1c1e1d5bf2

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_57b97b9a66b24f6bb99f6a1c1e1d5bf2

Other Identifiers

ISSN

1479-5876

E-ISSN

1479-5876

DOI

10.1186/s12967-024-05321-5

How to access this item